Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
34.6%
% of BBP's 55 holdings also in WDNA
20.2%
% of WDNA's 91 holdings also in BBP
Overlap by Weight
Sector Drift (BBP minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
BLUEPRINT MEDICINES CORP. | 2.0% | 2.2% | 2.0% |
|
CRISPR THERAPEUTICS AG | 2.4% | 1.8% | 1.8% |
|
BRIDGEBIO PHARMA, INC. | 1.8% | 2.0% | 1.8% |
|
AGIOS PHARMACEUTICALS INC | 2.5% | 1.6% | 1.6% |
|
ULTRAGENYX PHARMACEUTICAL IN | 2.1% | 1.6% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to WDNA
|
TARSUS PHARMACEUTICALS, INC. | 3.5% |
|
LEXICON PHARMACEUTICALS, INC. | 3.4% |
|
SPRINGWORKS THERAPEUTICS, INC. | 2.6% |
|
ADMA BIOLOGICS, INC. | 2.5% |
|
KINIKSA PHARMACEUTICALS LTD. CLASS A | 2.3% |
|
AMYLYX PHARMACEUTICALS, INC. | 2.3% |
|
ASCENDIS PHARMA A/S | 2.3% |
|
APELLIS PHARMACEUTICALS, INC. | 2.2% |
|
LIGAND PHARMACEUTICALS-CL B | 2.1% |
|
PTC THERAPEUTICS INC | 2.1% |
BBP Underweight Relative to WDNA
|
IOVANCE BIOTHERAPEUTICS INC | -3.9% |
|
TWIST BIOSCIENCE CORP. | -3.4% |
|
FATE THERAPEUTICS INC | -3.1% |
 |
NOVOZYMES A/S-B SHARES | -2.4% |
|
NATERA INC | -1.9% |
|
ELI LILLY & CO | -1.9% |
 |
ALCOBRA LTD | -1.7% |
|
VERICEL CORPORATION | -1.7% |
|
CARIBOU BIOSCIENCES, INC. | -1.6% |
|
EDITAS MEDICINE, INC. | -1.6% |